Olympus Launches Next-Generation Surgical Imaging Platform in U.S.

WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ -- Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization, workflow efficiency, and multispecialty flexibility. The VISERA ELITE III platform is a significant leap forward in surgical imaging and the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture established in 2013.

Designed to bring light, color, and clarity inside the human body, the VISERA ELITE™ III platform integrates advanced imaging technologies into a software-driven platform that supports minimally invasive surgery in a wide range of specialties. The advanced features in this next-generation surgical imaging platform include True 4K and 3D imaging, Continuous Auto Focus (CAF), Narrow Band Imaging™ (NBI) technology, Yellow Enhancement (YE), ENDOEYE™ rigid and flexible videoscopes, and Fluorescence-Guided Surgery (IR/ICG) — now in full 4K White Light and high contrast Magenta Mode. All these features are now available in a single system that may improve workflow and may support clinical decision making.

The versatile, multispecialty VISERA ELITE III platform supports a wide range of specialties including arthroscopy, colorectal, ENT, bariatric, thoracic, gynecological, urological, HPB transplant and general surgery. This flexibility across specialties and support for prior generation videoendoscopes* reflects Olympus’ commitment to scalable, clinical solutions that evolve with surgical teams’ needs.

Sign up for Blog Updates